Deutsche Bank Ag\ Frequency Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.03 - $2.03 $17,879 - $35,238	-17,359 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.7 - $5.72 $3,502 - $11,783	-2,060 Reduced 10.61%	17,359 $37,000
Q4 2021 Feb 11, 2022	SELL	$4.95 - $7.11 $20,181 - $28,987	-4,077 Reduced 17.35%	19,419 $100,000
Q3 2021 Nov 04, 2021	SELL	$6.96 - $9.25 $12,284 - $16,326	-1,765 Reduced 6.99%	23,496 $166,000
Q2 2021 Aug 11, 2021	BUY	$8.05 - $11.61 $53,097 - $76,579	6,596 Added 35.34%	25,261 $252,000
Q1 2021 May 13, 2021	SELL	$7.99 - $55.01 $21,077 - $145,116	-2,638 Reduced 12.38%	18,665 $177,000
Q4 2020 Feb 16, 2021	BUY	$18.65 - $40.0 $138,438 - $296,920	7,423 Added 53.48%	21,303 $750,000
Q3 2020 Nov 12, 2020	SELL	$17.76 - $24.96 $6,766 - $9,509	-381 Reduced 2.67%	13,880 $267,000
Q2 2020 Aug 13, 2020	BUY	$14.65 - $24.9 $178,539 - $303,456	12,187 Added 587.61%	14,261 $332,000
Q1 2020 May 14, 2020	BUY	$16.36 - $27.55 $2,404 - $4,049	147 Added 7.63%	2,074 $37,000
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $24,415 - $36,092	1,927 New	1,927 $33,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.